CASI Pharmaceuticals Inc (CASI) has risen 5.58% in a Week, Should You Accumulate?

A rating of 98 puts CASI Pharmaceuticals Inc (CASI) near the top of the Biotechnology industry according to InvestorsObserver. CASI Pharmaceuticals Inc's score of 98 means it scores higher than 98% of stocks in the industry. CASI Pharmaceuticals Inc also received an overall rating of 86, putting it above 86% of all stocks. Biotechnology is ranked 54 out of the 148 industries.

CASI has an Overall Score of 86. Find out what this means to you and get the rest of the rankings on CASI!

See Full CASI Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With CASI Pharmaceuticals Inc Stock Today?

CASI Pharmaceuticals Inc (CASI) stock has gained 5.59% while the S&P 500 is lower by -0.1% as of 10:15 AM on Tuesday, Nov 28. CASI is higher by $0.29 from the previous closing price of $5.20 on volume of 2,581 shares. Over the past year the S&P 500 has risen 14.68% while CASI is higher by 184.46%. CASI lost -$3.00 per share the over the last 12 months. Click Here to get the full Stock Report for CASI Pharmaceuticals Inc stock.